TumMeta Cancer Research Results

TumMeta, Cancer Metastasis: Click to Expand ⟱
Source:
Type:
Cancer metastasis is the process by which cancer cells spread from the original (primary) tumor to other parts of the body, forming new (secondary) tumors. This occurs when cancer cells invade surrounding tissues, enter the bloodstream or lymphatic system, and travel to distant organs or tissues.


GC, Gastric Adenocarcinoma: Click to Expand ⟱
Stomach/Gastric Cancer

Scientific Papers found: Click to Expand⟱
4993- ART/DHA,    Dihydroartemisinin inhibits galectin-1–induced ferroptosis resistance and peritoneal metastasis of gastric cancer via the Nrf2–HO-1 pathway
- vitro+vivo, GC, NA
Ferroptosis↑, NRF2↓, HO-1↓, PI3K↓, Akt↓, TumMeta↓,
5501- Ba,    Therapeutic effects and mechanisms of action of Baicalein on stomach cancer: a comprehensive systematic literature review
- Review, GC, NA
AntiCan↑, Apoptosis↑, TumCP↓, TumMeta↓, BAX↑, TumAuto↑, ROS↑, NRF2↝, PI3K↓, Akt↓, NF-kB↓, TGF-β↓, SMAD4↓, GPx4↓, MMP↓, *HO-1↑, *GSTs↑, *antiOx↑, *AntiTum↑, *NRF2↑, ChemoSen↑, Akt↓, mTOR↓, FAK↓, Ki-67↓,
16- Cyc,  RES,    Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis
- in-vitro, GC, SGC-7901
HH↓, Gli1↓, EMT↓, N-cadherin↓, E-cadherin↑, Snail↓, TumCI↓, TumMeta↓,
7220- EGb 761,    Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer
- vitro+vivo, GC, SGC-7901
TumCP↓, TumCMig↓, TumCI↓, p‑ERK↓, NF-kB↓, MMP2↓, eff↑, TumCG↓, TumMeta↓, Dose↝, TumVol↓,
5187- PEITC,    Phenethyl Isothiocyanate Inhibits Migration and Invasion of Human Gastric Cancer AGS Cells through Suppressing MAPK and NF-κB Signal Pathways
- in-vitro, GC, AGS
TumMeta↓, ERK↓, MKK7↓, PKCδ↓, Rho↓, uPA↓, MMP2↓, MMP9↓, RAS↓, VEGF↓, FAK↓, iNOS↓, COX2/PTGS2↓, TumCP↓,
101- RES,    Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis
- in-vitro, GC, SGC-7901
HH↓, Gli1↓, EMT↓, Snail↓, N-cadherin↓, E-cadherin↑, TumCI↓, TumMeta↓,
5035- SAS,    Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use
- Human, GC, NA - in-vitro, GC, NCI-N87 - in-vitro, GC, SGC-7901
other?, TumCP↓, TumMeta↓, TumCI↓, xCT/SLC7A11↓, OS↑,

Showing Research Papers: 1 to 7 of 7

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

Ferroptosis↑, 1,   GPx4↓, 1,   HO-1↓, 1,   NRF2↓, 1,   NRF2↝, 1,   ROS↑, 1,   xCT/SLC7A11↓, 1,  

Mitochondria & Bioenergetics(tgid=3)

MKK7↓, 1,   MMP↓, 1,  

Cell Death(tgid=5)

Akt↓, 3,   Apoptosis↑, 1,   BAX↑, 1,   Ferroptosis↑, 1,   iNOS↓, 1,  

Transcription & Epigenetics(tgid=7)

other?, 1,  

Autophagy & Lysosomes(tgid=9)

TumAuto↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

EMT↓, 2,   ERK↓, 1,   p‑ERK↓, 1,   Gli1↓, 2,   HH↓, 2,   mTOR↓, 1,   PI3K↓, 2,   RAS↓, 1,   TumCG↓, 1,  

Migration(tgid=13)

E-cadherin↑, 2,   FAK↓, 2,   Ki-67↓, 1,   MMP2↓, 2,   MMP9↓, 1,   N-cadherin↓, 2,   PKCδ↓, 1,   Rho↓, 1,   SMAD4↓, 1,   Snail↓, 2,   TGF-β↓, 1,   TumCI↓, 4,   TumCMig↓, 1,   TumCP↓, 4,   TumMeta↓, 7,   uPA↓, 1,  

Angiogenesis & Vasculature(tgid=14)

VEGF↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

COX2/PTGS2↓, 1,   NF-kB↓, 2,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↑, 1,   Dose↝, 1,   eff↑, 1,  

Clinical Biomarkers(tgid=22)

Ki-67↓, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 1,   OS↑, 1,   TumVol↓, 1,  
Total Targets: 51

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,   GSTs↑, 1,   HO-1↑, 1,   NRF2↑, 1,  

Functional Outcomes(tgid=23)

AntiTum↑, 1,  
Total Targets: 5

Scientific Paper Hit Count for: TumMeta, Cancer Metastasis
2 Resveratrol
1 Artemisinin
1 Baicalein
1 Cyclopamine
1 Ginkgo biloba-EGb 761
1 Phenethyl isothiocyanate
1 Sulfasalazine
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:28  Cells:%  prod#:%  Target#:604  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page